Count Me In

Count Me In (CMI) was a pioneering research initiative that was deeply committed to making every cancer patient’s experience count. Through participation, patients were empowered to help shape and propel research toward future changes in the course of cancer.

Since the launch of in 2015, thousands of people living with cancer from around the United States and Canada have said “Count Me In” to partnering directly with researchers from the ӳ��ý, to gain new insights into how tumors develop and why they often resist treatment.

From its inception, CMI placed patients at the center of discovery. By directly engaging individuals living with cancer and rare diseases through an innovative online platform, CMI built a powerful model for research — one rooted in trust, transparency, and the shared goal of accelerating scientific breakthroughs, no matter where patients lived or were treated.

In 2025, CMI joined ӳ��ý Clinical Labs to ensure long-term sustainability and scaling of patient-partnered research. To learn more about patient-partnered research initiatives at the ӳ��ý, visit /patient-partnered-research.

Data and publications

Data from the CMI projects are available for use by cancer researchers worldwide. CMI datasets are hosted on cBioPortal and dbGap. Additional data will be made available as new datasets are collected and assessed for quality assurance and quality control.

Angiosarcoma Project (, )
Metastatic Breast Cancer Project (l, )
Metastatic Prostate Cancer Project (, )

Publications stemming from CMI projects and data are indexed in the ӳ��ý publications archive.

Note on data access

dbGap is a controlled-access database operated by the National Institutes of Health (NIH). Access to CMI data stored on dbGap is governed by the NIH's .